Jump to content

Pseudocholinesterase deficiency: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
edit link
m checked refences, updates date info.
Line 1: Line 1:
'''Pseudocholinesterase deficiency''' is an inherited [[blood plasma]] [[enzyme]] abnormality. People who have this abnormality may be sensitive to certain [[anesthesia|anesthetic]] drugs, including the muscle relaxants [[succinylcholine]] and [[mivacurium]] as well as other [[ester]] local anesthetics (Maiorana & Roach, 2003). These drugs are normally [[metabolism|metabolized]] by the [[pseudocholinesterase]] enzyme.
'''Pseudocholinesterase deficiency''' is an inherited [[blood plasma]] [[enzyme]] abnormality. People who have this abnormality may be sensitive to certain [[anesthesia|anesthetic]] drugs, including the muscle relaxants [[succinylcholine]] and [[mivacurium]] as well as other [[ester]] local anesthetics <ref> Maiorana, Anthony & Roach, Robert B. (2003). "Heterozygous pseudocholinesterase deficiency: a case report and review of the literature". Journal of Oral and Maxillofacial Surgery. 61 (7), 845-847. [http://www.joms.org/ JOMS]. Retrieved Mar. 13, 2007.</ref>. These drugs are normally [[metabolism|metabolized]] by the [[pseudocholinesterase]] enzyme.


When anesthetists administer standard doses of these drugs to a person with pseudocholinesterase deficiency, the patient experiences prolonged paralysis of his respiratory muscles, requiring an extended period of time during which the patient must be mechanically [[medical ventilator|ventilated]]. Eventually the muscle-paralyzing effects of these drugs will wear off despite the deficiency of the pseudocholinesterase enzyme. If the patient is maintained on a mechanical respirator until normal breathing function returns, there is little risk of harm to the patient. This enzyme abnormality is a [[benign]] condition unless a person with pseudocholinesterase deficiency is exposed to the offending [[pharmacology|pharmacological]] agents (Alexander, 2002).
When anesthetists administer standard doses of these drugs to a person with pseudocholinesterase deficiency, the patient experiences prolonged paralysis of his respiratory muscles, requiring an extended period of time during which the patient must be mechanically [[medical ventilator|ventilated]]. Eventually the muscle-paralyzing effects of these drugs will wear off despite the deficiency of the pseudocholinesterase enzyme. If the patient is maintained on a mechanical respirator until normal breathing function returns, there is little risk of harm to the patient. This enzyme abnormality is a [[benign]] condition unless a person with pseudocholinesterase deficiency is exposed to the offending [[pharmacology|pharmacological]] agents<ref>Alexander, Daniel R. (2002). [http://www.emedicine.com/med/topic1935.htm Pseudocholinesterase deficiency]. Retrieved Mar. 13, 2007.</ref>.


==References==
==References==
<references />
* Alexander, Daniel R. (2002). [http://www.emedicine.com/med/topic1935.htm Pseudocholinesterase deficiency]. Retrieved Jun. 10, 2005.
* Maiorana, Anthony & Roach, Robert B. (2003). [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12856264&dopt=Abstract "Heterozygous pseudocholinesterase deficiency: a case report and review of the literature".] ''Journal of Oral and Maxillofacial Surgery.'' '''61''' (7), 845-847.


[[Category:Enzymes]]
[[Category:Enzymes]]

Revision as of 11:09, 13 March 2007

Pseudocholinesterase deficiency is an inherited blood plasma enzyme abnormality. People who have this abnormality may be sensitive to certain anesthetic drugs, including the muscle relaxants succinylcholine and mivacurium as well as other ester local anesthetics [1]. These drugs are normally metabolized by the pseudocholinesterase enzyme.

When anesthetists administer standard doses of these drugs to a person with pseudocholinesterase deficiency, the patient experiences prolonged paralysis of his respiratory muscles, requiring an extended period of time during which the patient must be mechanically ventilated. Eventually the muscle-paralyzing effects of these drugs will wear off despite the deficiency of the pseudocholinesterase enzyme. If the patient is maintained on a mechanical respirator until normal breathing function returns, there is little risk of harm to the patient. This enzyme abnormality is a benign condition unless a person with pseudocholinesterase deficiency is exposed to the offending pharmacological agents[2].

References

  1. ^ Maiorana, Anthony & Roach, Robert B. (2003). "Heterozygous pseudocholinesterase deficiency: a case report and review of the literature". Journal of Oral and Maxillofacial Surgery. 61 (7), 845-847. JOMS. Retrieved Mar. 13, 2007.
  2. ^ Alexander, Daniel R. (2002). Pseudocholinesterase deficiency. Retrieved Mar. 13, 2007.